Explore Rankings
Journal profile · Pharmacology, Toxicology and Pharmaceutics

Expert Opinion on Drug Delivery

Taylor & Francis · United Kingdom · ISSN 1742-5247, 1744-7593

ITS Journal Score83.0
Global rank#1,256
Rank in Pharmacology, Toxicology and Pharmaceutics#5 of 168
h-index161
Open access 2021–202535%

Overview

Expert Opinion on Drug Delivery, published by Taylor & Francis (United Kingdom), published 592 papers in 2021–2025, and its papers received 9,791 citations in those years. Its h-index is 161 and its two-year mean citedness is 6.77. On the ITS Journal Score it ranks #1,256 of 62,158 ranked journals and #5 of 168 in Pharmacology, Toxicology and Pharmaceutics.

Key figures

Papers 2021–2025592
Citations 2021–20259,791
Citations per paper16.5
h-index161
i10-index1,948
2-year mean citedness6.77
Open-access share35%
Change in papers, 2020→2025-2%
Article fee (APC)Not recorded

Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.

Papers and citations by year

YearPapersCitations receivedOpen-access papers
20201697,63359
2021712,17920
20221163,09034
20231072,08146
20241321,50643
202516693565

What it publishes

The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.

Similar journals

Ranked journals that publish on the same topics.

JournalFieldScorePapers 2021–2025Open access
Journal of Drug Delivery Science and TechnologyPharmacology, Toxicology and Pharmaceutics81.85,12219%
Current Drug DeliveryPharmacology, Toxicology and Pharmaceutics73.35966%
Drug DeliveryPharmacology, Toxicology and Pharmaceutics81.6768100%
European Journal of Pharmaceutics and BiopharmaceuticsPharmacology, Toxicology and Pharmaceutics84.41,33546%
Drug Delivery and Translational ResearchPharmacology, Toxicology and Pharmaceutics82.21,14848%
PharmaceuticsPharmacology, Toxicology and Pharmaceutics88.611,136100%
Drug Delivery LettersPharmacology, Toxicology and Pharmaceutics48.31626%
International Journal of PharmaceuticsPharmacology, Toxicology and Pharmaceutics88.75,63535%

Compare with similar journals (side by side with the two closest journals above)

Identity and sources

  • ISSN-L: 1742-5247
  • Print ISSN: 1742-5247
  • Electronic ISSN: 1744-7593
  • Publisher: Taylor & Francis
  • Listed in DOAJ: Not yet checked
  • Crossref: ISSN found in Crossref
  • OpenAlex: S51663496
  • Journal website: www.tandfonline.com

Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.

Questions

What is the ITS Journal Score of Expert Opinion on Drug Delivery?

It is 83.0 out of 100, which places it #1,256 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.

What is the impact factor of Expert Opinion on Drug Delivery?

This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 6.77.

Is Expert Opinion on Drug Delivery open access?

35% of its papers from 2021–2025 are recorded as open access.

Does Expert Opinion on Drug Delivery charge a publication fee?

No fee is recorded in the open data used here. Check the journal's own website for its current fees.

Transparent methodology

How the ITS Journal Score works

One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.

A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.

What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.